{"component": "definition", "props": {"groups": [{"snippet_links": [], "samples": [{"hash": "j0Xs9os43FO", "uri": "/contracts/j0Xs9os43FO#required-changes", "label": "Manufacturing Agreement", "score": 31.3408622742, "published": true}, {"hash": "gdFjTqm2v1J", "uri": "/contracts/gdFjTqm2v1J#required-changes", "label": "Manufacturing Agreement (Reliant Pharmaceuticals, Inc.)", "score": 21.0, "published": true}, {"hash": "dKDT4yR6UW", "uri": "/contracts/dKDT4yR6UW#required-changes", "label": "Manufacturing Agreement (Reliant Pharmaceuticals, Inc.)", "score": 21.0, "published": true}], "size": 17, "snippet": "has the meaning set forth in Section 4.7(b).", "hash": "0b64d785285c42039521058d50a75aa8", "id": 1}, {"snippet_links": [{"key": "section-48", "type": "clause", "offset": [41, 52]}], "samples": [{"hash": "90zQQhEK3FI", "uri": "/contracts/90zQQhEK3FI#required-changes", "label": "Methylphenidate Supply Agreement (Osmotica Pharmaceuticals PLC)", "score": 29.7008895874, "published": true}, {"hash": "kKGL0C9CewB", "uri": "/contracts/kKGL0C9CewB#required-changes", "label": "Methylphenidate Supply Agreement (Osmotica Pharmaceuticals LTD)", "score": 29.6379184723, "published": true}, {"hash": "eBf7KkVWywC", "uri": "/contracts/eBf7KkVWywC#required-changes", "label": "Methylphenidate Supply Agreement (Osmotica Pharmaceuticals LTD)", "score": 29.3504447937, "published": true}], "size": 3, "snippet": "shall have the meaning ascribed to it in Section 4.8.", "hash": "580ae98229e050c12b35f87301fffc1c", "id": 2}, {"snippet_links": [], "samples": [{"hash": "dQygVlvytiV", "uri": "/contracts/dQygVlvytiV#required-changes", "label": "Supply Agreement (Correvio Pharma Corp.)", "score": 29.5256671906, "published": true}, {"hash": "3IuUT5oBKTI", "uri": "/contracts/3IuUT5oBKTI#required-changes", "label": "Supply Agreement (Cardiome Pharma Corp)", "score": 27.3737163544, "published": true}], "size": 3, "snippet": "shall have the meaning set forth in Section 5.5(a).", "hash": "7c1cd3e585b913b9724b1b53727af945", "id": 3}, {"snippet_links": [{"key": "section-63", "type": "clause", "offset": [29, 40]}], "samples": [{"hash": "45d1fMJuT5g", "uri": "/contracts/45d1fMJuT5g#required-changes", "label": "Dedicated Manufacturing and Commercial Supply Agreement (Freeline Therapeutics Holdings LTD)", "score": 31.5215606689, "published": true}], "size": 3, "snippet": "has the meaning set forth in Section 6.3.", "hash": "603d8771bc7814c7e732dff2d8fd7e38", "id": 4}, {"snippet_links": [], "samples": [{"hash": "b7WFOkUGdu1", "uri": "/contracts/b7WFOkUGdu1#required-changes", "label": "License and Supply Agreement (Ligand Pharmaceuticals Inc)", "score": 21.3709793091, "published": true}, {"hash": "dKw5ibxF1f", "uri": "/contracts/dKw5ibxF1f#required-changes", "label": "License and Supply Agreement (Ligand Pharmaceuticals Inc)", "score": 21.143737793, "published": true}], "size": 2, "snippet": "has the meaning specified in Section 3.10(b).", "hash": "22d9474ac626d0cf5af819ba3f293798", "id": 5}, {"snippet_links": [], "samples": [{"hash": "1JH48c2S7iC", "uri": "/contracts/1JH48c2S7iC#required-changes", "label": "Manufacturing Agreement (Prestige Personal Care, Inc.)", "score": 18.0, "published": true}], "size": 1, "snippet": "shall have the meaning set forth in SECTION 4.3(a).", "hash": "fd0ced34f42cbf74be1e80f7375780ab", "id": 6}, {"snippet_links": [], "samples": [{"hash": "5mvcl2kMKtV", "uri": "/contracts/5mvcl2kMKtV#required-changes", "label": "License and Collaboration Agreement (Amicus Therapeutics Inc)", "score": 23.8473644257, "published": true}], "size": 1, "snippet": "has the meaning ascribed to that term in Section 6.5.6.", "hash": "f5a2245a45945e76d8b61e04376e53b4", "id": 7}, {"snippet_links": [{"key": "section-174", "type": "clause", "offset": [41, 53]}], "samples": [{"hash": "2wQ6ShBPws1", "uri": "/contracts/2wQ6ShBPws1#required-changes", "label": "Purchase and Sale Agreement (Prime Group Realty Trust)", "score": 21.3613967896, "published": true}], "size": 1, "snippet": "has the meaning ascribed to such term in Section 17.4.", "hash": "4eb6d49a38546ccd77516a7162f1f95f", "id": 8}, {"snippet_links": [{"key": "change-request", "type": "clause", "offset": [8, 22]}, {"key": "from-customer", "type": "clause", "offset": [23, 36]}, {"key": "change-in-applicable-law", "type": "definition", "offset": [70, 94]}, {"key": "policy-change", "type": "definition", "offset": [107, 120]}, {"key": "commonwealth-funding", "type": "definition", "offset": [140, 160]}, {"key": "in-accordance-with", "type": "definition", "offset": [161, 179]}, {"key": "pursuant-to-mass", "type": "clause", "offset": [197, 213]}, {"key": "availability-of", "type": "clause", "offset": [246, 261]}, {"key": "appropriated-funds", "type": "definition", "offset": [277, 295]}, {"key": "prime-contract", "type": "definition", "offset": [316, 330]}, {"key": "adjustment-of", "type": "clause", "offset": [343, 356]}, {"key": "change-in-the-project", "type": "clause", "offset": [371, 392]}, {"key": "required-by", "type": "definition", "offset": [406, 417]}], "samples": [{"hash": "d2xSrI9Opyp", "uri": "/contracts/d2xSrI9Opyp#required-changes", "label": "Professional Services Agreement", "score": 21.3750858307, "published": true}], "size": 1, "snippet": "means a change request from Customer that arises as a result of (i) a change in applicable Law, (ii) a CMS policy change, (iii) a change in Commonwealth funding in accordance with an appropriation pursuant to Mass. Gen. Laws. c. 29, \u00a7 26, or the availability of sufficient non-appropriated funds for purposes of the Prime Contract, or (iv) an adjustment of priorities or change in the Project requested or required by CMS.", "hash": "0edde4c73e94c284de199978402ebd8a", "id": 9}, {"snippet_links": [{"key": "section-59", "type": "clause", "offset": [29, 40]}, {"key": "section-72", "type": "clause", "offset": [87, 98]}, {"key": "safety-stock", "type": "definition", "offset": [106, 118]}, {"key": "section-55", "type": "clause", "offset": [149, 160]}, {"key": "senior-executives", "type": "clause", "offset": [168, 185]}, {"key": "section-31", "type": "clause", "offset": [216, 227]}, {"key": "by-lonza", "type": "clause", "offset": [282, 290]}, {"key": "statement-of-work", "type": "definition", "offset": [299, 316]}, {"key": "a-purchase-order", "type": "definition", "offset": [318, 334]}, {"key": "quality-agreement", "type": "definition", "offset": [342, 359]}, {"key": "manufacture-of-the-product", "type": "clause", "offset": [375, 401]}, {"key": "provision-of", "type": "clause", "offset": [410, 422]}, {"key": "testing-services", "type": "clause", "offset": [423, 439]}, {"key": "storage-services", "type": "clause", "offset": [470, 486]}, {"key": "shortage-of-supply", "type": "clause", "offset": [494, 512]}, {"key": "the-applicable", "type": "clause", "offset": [590, 604]}, {"key": "msc-product", "type": "definition", "offset": [644, 655]}, {"key": "mpc-product", "type": "definition", "offset": [659, 670]}, {"key": "standard-operating-procedure", "type": "definition", "offset": [741, 769]}, {"key": "with-respect-to", "type": "clause", "offset": [863, 878]}, {"key": "certificate-of-analysis", "type": "clause", "offset": [922, 945]}, {"key": "in-writing", "type": "clause", "offset": [977, 987]}, {"key": "in-connection-with", "type": "clause", "offset": [989, 1007]}, {"key": "manufacturing-activities", "type": "clause", "offset": [1147, 1171]}, {"key": "the-process", "type": "clause", "offset": [1192, 1203]}, {"key": "other-services", "type": "clause", "offset": [1219, 1233]}, {"key": "each-case", "type": "definition", "offset": [1238, 1247]}, {"key": "agreed-to-and-signed-by-the-parties", "type": "clause", "offset": [1445, 1480]}, {"key": "this-agreement", "type": "clause", "offset": [1548, 1562]}, {"key": "consecutively-numbered", "type": "definition", "offset": [1576, 1598]}, {"key": "for-clarity", "type": "clause", "offset": [1622, 1633]}, {"key": "made-pursuant-to", "type": "clause", "offset": [1706, 1722]}, {"key": "purchase-orders", "type": "clause", "offset": [1723, 1738]}, {"key": "section-94", "type": "clause", "offset": [1807, 1818]}, {"key": "technology-transfer", "type": "definition", "offset": [1826, 1845]}, {"key": "section-42", "type": "clause", "offset": [1876, 1887]}, {"key": "section-141", "type": "clause", "offset": [1930, 1942]}], "samples": [{"hash": "e652gJ05CDj", "uri": "/contracts/e652gJ05CDj#required-changes", "label": "Manufacturing Services Agreement (Mesoblast LTD)", "score": 33.6577686516, "published": true}], "size": 1, "snippet": "has the meaning set forth in Section 5.9. 1.81 \u201cResponse\u201d has the meaning set forth in Section 7.2. 1.82 \u201cSafety Stock\u201d has the meaning set forth in Section 5.5. 1.83 \u201cSenior Executives\u201d has the meaning set forth in Section 3.1. 1.84 \u201cServices\u201d means the activities to be performed by LONZA under a Statement of Work, a Purchase Order or the Quality Agreement, including the manufacture of the Product and the provision of testing services, quality control services and storage services. 1.85 \u201cShortage of Supply\u201d has the meaning set forth in Section 5.5. 1.86 \u201cSlot\u201d means the capacity in the applicable suite to: manufacture one (1) batch of MSC Product or MPC Product or perform one (1) aseptic process simulation run. 1.87 \u201cSOP\u201d means a standard operating procedure. 1.88 \u201cSourcing Plan\u201d has the meaning set forth in Section 3.1. 1.89 \u201cSpecifications\u201d means, with respect to a Product, specifications set forth in the certificate of analysis or as modified by the Parties, in writing, in connection with the manufacture of a particular cGMP Batch of such Product hereunder, [***]. 1.90 \u201cStatement of Work\u201d or \u201cSOW\u201d means a plan to perform pre-manufacturing activities, to further develop the Process, or to perform other Services, in each case, which is agreed upon by the Parties and attached hereto as an Appendix. It is contemplated that each separate project shall have its own Statement of Work. As each subsequent Statement of Work is agreed to and signed by the Parties, each shall state that it is to be incorporated and made a part of this Agreement and shall be consecutively numbered as A-1, A-2, A-3, etc. For clarity, the Parties anticipate that orders of MSC Product cGMP Batches will be made pursuant to Purchase Orders and not pursuant to SOWs. 1.91 \u201cTaxes\u201d has the meaning set forth in Section 9.4. 1.92 \u201cTechnology Transfer\u201d has the meaning set forth in Section 4.2. 1.93 \u201cTerm\u201d has the meaning set forth in Section 14.1. 1.94 \u201cTerritory\u201d means [***].", "hash": "6106b0c234375c957d39928551714efc", "id": 10}], "next_curs": "Cl0SV2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjkLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIZcmVxdWlyZWQtY2hhbmdlcyMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Required Changes", "size": 35, "snippet": "has the meaning set forth in Section 4.7(b).", "id": "required-changes", "examples": ["Any such modifications and amendments are referred to herein as a \u201cRequired Change.\u201d ICANN\u2019s right to implement <strong>Required Changes</strong> under this Supplement shall expire on 15 January 2014.", "Any such modifications and amendments are referred to herein as a \u201cRequired Change.\u201d ICANN\u2019s right to implement <strong>Required Changes</strong> under this Supplement shall expire one hundred eighty (180) calendar days after the date of this Supplement.", "Any and all costs associated with (i) <strong>Required Changes</strong> initiated by either Party, or (ii) Discretionary Changes initiated by the Buyer shall be borne by the Buyer.", "Seller shall consider in good faith any request by Buyer to make changes to the Product Specifications or Manufacturing that are not <strong>Required Changes</strong>, including, but not limited to, changes to the existing Product, Product line extensions, or changes to the existing or additional packaging (collectively, \u201cDiscretionary Changes\u201d).", "Buyer shall, in the case of an Buyer-Initiated Change or, if it elects to do so, in the case of Seller Initiated Changes, and in all events in the case of <strong>Required Changes</strong>, thereafter issue such Change Order having regard to all such circumstances as is just and equitable and in a form substantially similar to the Change Order Form attached hereto as Exhibit D-1 which shall address, to the extent required, all of the issues set out in this Section 13.1(c).", "Any and all costs associated with <strong>Required Changes</strong> shall be borne by Hospira.", "<strong>Required Changes</strong> may extend to drawings and specifications for the Product and the scope of work covered by the applicable Purchase Order, including such matters as inspection, testing, quality control, and other matters ancillary to the production of the Product.", "Prior to implementation, all <strong>Required Changes</strong> shall be subject to CLIENT\u2019s written approval, including without limitation the timelines, estimated effect on costs to manufacture such Product and other issues regarding such implementation.", "LONZA shall implement such <strong>Required Changes</strong> in accordance with any Applicable Laws and written instructions provided by CLIENT, and the terms and conditions set forth in Article 3.", "The Parties shall use commercially reasonable efforts in making any <strong>Required Changes</strong> promptly."], "related": [["proposed-change", "Proposed Change", "Proposed Change"], ["required-consent", "Required Consent", "Required Consent"], ["section-502b10-changes", "Section 502(b)(10) changes", "Section 502(b)(10) changes"], ["required-governmental-approvals", "Required Governmental Approvals", "Required Governmental Approvals"], ["final-approval", "Final Approval", "Final Approval"]], "related_snippets": [], "updated": "2025-08-31T05:44:20+00:00"}, "json": true, "cursor": ""}}